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There is increasing evidence that a fine-tuned integrin cross talk can generate a high degree of
specificity in cell adhesion, suggesting that spatially and temporally coordinated expression and
activation of integrins are more important for regulated cell adhesive functions than the intrinsic
specificity of individual receptors. However, little is known concerning the molecular mechanisms
of integrin cross talk. With the use of 1-null GD25 cells ectopically expressing the 1A integrin
subunit, we provide evidence for the existence of a cross talk between 1 and V integrins that
affects the ratio of V3 and V5 integrin cell surface levels. In particular, we demonstrate that a
down-regulation of V3 and an up-regulation of V5 occur as a consequence of 1A expression.
Moreover, with the use of GD25 cells expressing the integrin isoforms 1B and 1D, as well as two
1 cytoplasmic domain deletion mutants lacking either the entire cytoplasmic domain (1TR) or
only its “variable” region (1COM), we show that the effects of 1 over V integrins take place
irrespective of the type of 1 isoform, but require the presence of the “common” region of the 1
cytoplasmic domain. In an attempt to establish the regulatory mechanism(s) whereby 1 integrins
exert their trans-acting functions, we have found that the down-regulation of V3 is due to a
decreased 3 subunit mRNA stability, whereas the up-regulation of V5 is mainly due to
translational or posttranslational events. These findings provide the first evidence for an integrin
cross talk based on the regulation of mRNA stability.
INTRODUCTION
Integrins form one family of cell adhesion receptors that
play a prominent role in the adhesive interactions between
cells and their surrounding extracellular matrix (ECM)
(Hynes, 1992). All integrins are heterodimers composed of
noncovalently linked  and  subunit transmembrane gly-
coproteins containing large extracellular domains, short
transmembrane domains, and carboxyl-terminal cytoplas-
mic domains of variable length (Hynes, 1992). These adhe-
sive receptors are endowed with both structural and regu-
latory functions, linking extracellular matrix to the actin
cytoskeleton at focal adhesion sites and providing bidirec-
tional transmission of signals across the plasma membrane
(Schoenwaelder and Burridge, 1999; Critchley, 2000). The
cytoplasmic domain of the  subunit has been shown to play
a critical role in focal adhesion and actin stress fiber organi-
zation and both outside-in and inside-out integrin signaling
(Liu et al., 2000).
Through their molecular interactions integrins regulate a
number of critical cellular processes, including proliferation,
differentiation, survival, migration, and gene expression (Gi-
ancotti, 1997; Giancotti and Ruoslahti, 1999). It is now clear
that altered, modulated, or regulated adhesive interactions
can change the way cells interact with their environment
with dramatic consequences for both normal and patholog-
ical conditions. Cells can vary their adhesive properties by
selectively expressing different integrins and by modulating
their integrin specificity and affinity for ligands (Hynes,
1996). However, cells often display multiple integrins capa-
ble of interacting with a particular ECM protein and, con-
versely, individual integrins can recognize several extracel-
lular matrix molecules (Hynes, 1992). Thus, integrin
expression and ligand specificity are often apparently re-
dundant, at least in terms of simple adhesion. The biological
significance of this phenomenon is not clear yet; neverthe-
less, there is increasing evidence that individual integrin
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receptors mediate distinct functions and can convey unique
information (Giancotti, 2000).
Most integrins belong to one of two major subfamilies
defined by the 1 and V subunits. The 1 subunit pairs with
at least 12 different  subunits (1-11, V) to comprise
receptors for a variety of ECM proteins, including collagen,
laminin, fibronectin, and vitronectin (Hynes, 1992). A large
body of literature (Brakebusch et al., 1997; Giancotti, 1997;
reviewed in Schoenwaelder and Burridge, 1999) has ad-
dressed the role of 1 integrins in mediating important cell
adhesion and signal transduction events. Four different 1
isoforms have been identified (1A, 1B, 1C, and 1D),
which differ in their cytoplasmic domains and differentially
affect many integrin functions (Belkin et al., 1997; Fornaro
and Languino, 1997; Belkin and Retta, 1998; Pfaff et al., 1998;
Retta et al., 1998).
The V subunit is known to associate with at least five
different  subunits (1, 3, 5, 6, and 8). Among these V
integrins, V3 and V5 have been extensively studied. The
V3 integrin, in particular, has a relatively limited cellular
and tissue distribution (Yamada et al., 1995), but its expres-
sion and activity are tightly regulated during a variety of
biological processes, including cell proliferation and sur-
vival (Montgomery et al., 1994), wound healing (Clark et al.,
1996a), angiogenesis (Brooks et al., 1994), bone remodeling
(McHugh et al., 2000), tumor progression (Albelda et al.,
1990) and metastasis (Yun et al., 1996). This integrin can bind
to a variety of ECM proteins, including vitronectin, fibronec-
tin, fibrinogen, thrombospondin, Von Willebrand factor, and
denatured collagen (Kühn and Eble, 1994), and it is able to
recruit cytoskeletal and signaling proteins to focal adhesion
sites (Lewis et al., 1996). In addition, V3 is one of the
integrins that promotes the assembly of fibronectin matrix
(Wennerberg et al., 1996; Wu et al., 1996; Retta et al., 1998).
In contrast to V3, V5 is among the most widely ex-
pressed integrins. This receptor can specifically and effi-
ciently bind its ligand vitronectin but remains randomly
distributed over the surface of the cells and does not trigger
the assembly of focal adhesion structures (Wayner et al.,
1991; Leavesley et al., 1992). Moreover, V5 integrin has
different requirements than V3 for mediating adhesive
events, such as cell spreading and migration, to the common
ligand vitronectin (Klemke et al., 1994; Lewis et al., 1996), and
it can induce differential biological responses (Friedlander et
al., 1995).
Perturbation experiments with antibodies, blocking pep-
tides, and antisense oligonucleotides demonstrated that
both 1 and V integrins play a primary role in important
physiological and pathological processes (reviewed in Var-
ner and Cheresh, 1996; Brakebusch et al., 1997; Bader et al.,
1998). However, recent genetic analyses have clearly in-
creased questions as to the primacy of these integrins, and
instead have pointed to a cross talk model where spatiotem-
poral regulation, combinatorial expression, and activation of
several integrin receptors generate a high degree of speci-
ficity in cell adhesion (Fassler et al., 1996; Hynes, 1996, 1999;
Brakebusch et al., 1997; Bader et al., 1998; Hodivala-Dilke et
al., 1999; McHugh et al., 2000). Several observations indicate
the existence of a cross talk between 1 and V integrins,
which usually takes the form of one integrin influencing the
functional behavior of another integrin expressed on the
same cell (Yang and Hynes, 1996; Belkin et al., 1997; Retta et
al., 1998; Blystone et al., 1999; Corbett and Schwarzbauer,
1999). However, in most cases, the mechanistic basis of this
receptor cross talk is not completely understood, and it is
unknown whether and how the integrin cross talk can reg-
ulate the ratio of integrin cell-surface expression levels.
GD25 cells, derived from 1-null mouse embryonic stem
cells (Wennerberg et al., 1996), are a valuable model for
examination of integrin cross talk. In fact, these cells express
V3, V5, and 64 as major integrin complexes but do not
express integrins of the 1 subfamily, thus permitting a
variety of genetic experiments exploring the basis of integrin
cross talk. We have previously transfected GD25 cells with
cDNAs encoding for the isoform A, B, or D of the human 1
integrin subunit or two 1 mutants lacking either the entire
cytoplasmic domain (1TR) or only the cytoplasmic domain
“variable” region that characterizes each isoform (1COM)
(Retta et al., 1998). With the use of these cells, we investi-
gated the specific functional properties of the isoform B and
D of the human 1 integrin subunit, showing the existence of
a functional cross talk between these two 1 isoforms and
the endogenous V integrins. In particular, both 1B and
1D expression prevented different fibronectin (FN)-depen-
dent V integrin functions, including its ability to mediate
cell adhesion, to localize to focal adhesions, and to assemble
an FN matrix (Belkin et al., 1997; Retta et al., 1998).
In the present study, we show that the cross talk between
1 and V integrins is mainly based on the regulation of 3
and 5 integrin subunit expression exerted by 1 integrins.
In fact, the ectopic expression of either 1A, 1B, or 1D in
GD25 cells induces a drastic down-regulation of 3 and an
up-regulation of 5 integrin cell surface levels. Moreover,
analysis of GD25 cells expressing 1 integrins lacking either
the entire 1 cytoplasmic domain (1TR) or only its variable
region (1COM) demonstrate that the “common” region of
the 1 cytoplasmic domain is required for these effects. We
further demonstrate that 1 exerts its control over v3
expression level by modulating the 3 mRNA stability,
whereas the up-regulation of V5 is mainly due to transla-
tional or posttranslational events leading to an increased
recruitment of the 5 subunit at the cell surface.
MATERIALS AND METHODS
Antibodies and Reagents
The mouse anti-human 1 monoclonal antibody (mAb) TS2/16 was
obtained from American Type Culture Collection (Manassas, VA).
The rat anti-mouse 6 mAb GoH3 was a gift from A. Sonnenberg
(The Netherlands Cancer Institute, Amsterdam, The Netherlands).
The rabbit polyclonal antisera to V, 3, and 5 integrin cytoplasmic
domains, produced in our laboratory, were previously described
(Retta et al., 1998). The polyclonal antisera to 3 and 5 were pro-
duced with the use of a previously described protocol (Defilippi et
al., 1995). Briefly, rabbits were immunized against a GST-3 fusion
protein containing the cytoplasmic domain of the mouse 3 integrin
subunit and against a synthetic peptide reproducing an amino acid
sequence from the carboxy terminus of mouse 5 integrin subunit,
respectively. The 5 peptide EKAQLKPPATSDA was synthesized
by solid phase methods with the use of an LKB Biolynx synthesizer
(Amersham Pharmacia Biotech AB, Uppsala, Sweden) and coupled
to keyhole limpet hemocyanin with the use of glutaraldehyde. The
mouse anti-paxillin mAb was purchased from Transduction Labo-
ratories (Nottingham, United Kingdom). The affinity-purified rhoda-
mine-labeled goat anti-mouse and goat anti-rabbit IgG were from
Sigma (St. Louis, MO). Poly-l-lysine and monensin were from
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Sigma. Vitronectin and fibronectin were purified from human
plasma as previously described (Balzac et al., 1994; Retta et al., 1999).
Protein A-Sepharose and protein G-Sepharose were from Amer-
sham Pharmacia Biotech AB.
Cells and Culture Conditions
The mouse GD25 fibroblast line, which lacks expression of 1 inte-
grin heterodimers because of disruption of the 1 gene by homolo-
gous recombination, was established after differentiation of 1-null
embryonic stem cells and immortalization with simian virus 40
large T antigen (Wennerberg et al., 1996). GD25 cells expressing the
human 1A, 1B, or 1D integrin isoforms or the 1TR and 1COM
human 1 mutants, lacking the entire cytoplasmic domain and the
cytoplasmic domain variable region, respectively, were obtained as
previously described (Belkin et al., 1997; Retta et al., 1998). To avoid
selection for anomalous functional traits, no efforts were made to
establish clonal cell lines; instead, bulk cell populations expressing
1 integrins were selected. Cells were cultured in DMEM (Invitro-
gen Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS)
(Invitrogen), 2 mM l-glutamine, 100 U/ml penicillin, and 100
g/ml streptomycin. The 1-expressing GD25 cells were cultured in
the same medium plus 300 g/ml hygromycin B (Roche Molecular
Biochemicals, Mannheim, Germany). Cell populations expressing
high levels of the 1 forms used were selected by the panning
method and monitored by flow cytometry as described previously
(Retta et al., 1998).
Biotinylation of Cell Surface Proteins
Adherent cells, grown to 80–90% confluence in 90-mm tissue cul-
ture dishes, were washed twice with ice-cold buffer A (1.3 mM
CaCl2, 0.4 mM MgSO4, 5 mM KCl, 138 mM NaCl, 5,6 mM d-glucose,
25 mM HEPES, pH 7.4) and incubated with 0.5 mg/ml membrane-
impermeable biotinylation reagent Sulfo-NHS-Biotin (Sigma) in
buffer A at 4°C for 30 min. The reaction was quenched with DMEM
containing 0.6% bovine serum albumin (BSA) and 25 mM HEPES,
pH 7.4. The cells were then washed four times with ice-cold buffer
A and lysed on ice in Tris-buffered saline (150 mM NaCl, 20 mM
Tris-HCl, pH 7.4) containing 0.5% Triton X-100 and the protease
inhibitors aprotinin (10 g/ml), leupeptin (10 g/ml), phenylmeth-
ylsulfonyl fluoride (1 mM), and benzamidine (1 mM) (all from
Sigma). Cell lysates were centrifuged at 12,000  g for 30 min at 4°C,
and total protein concentration in the supernatants was determined
with the use of a bicinchoninic acid protein assay (Pierce, Rockford,
IL). Supernatants containing equal amounts of proteins were pre-
cleared with a mixture of protein A-Sepharose and protein G-
Sepharose and used in immunoprecipitation experiments.
Immunoprecipitation and Analysis of Integrins
Integrins were immunoprecipitated from precleared cell lysate su-
pernatants by incubation with appropriate dilutions of specific an-
tibodies and a mixture of protein A-Sepharose and protein G-
Sepharose beads for 1 h at 4°C. Complexes were washed four times
with the lysis buffer then the proteins were eluted with Laemmli’s
sample buffer (62.5 mM Tris-HCl, pH 6.8, 20% glycerol, 2% SDS)
and subjected to SDS-polyacrilamide (7.5%) gel electrophoresis un-
der nonreducing conditions. To visualize the biotinylated proteins,
the gel was electroblotted onto Hybond-C transfer membrane (Am-
ersham Pharmacia Biotech AB). The blot was then blocked with 5%
BSA in phosphate-buffered saline (PBS) for 1 h at 42°C, incubated
with streptavidin-peroxidase (Sigma) (1:10.000 in PBS/1% BSA) for
1 h at room temperature, and further processed by the Western
blotting enhanced chemiluminescence (ECL) detection system (Am-
ersham Pharmacia Biotech AB).
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR) and Northern Blot Analysis
Total RNA was isolated from 1  107 cultured cells with the use of
the RNeasy Mini kit (QIAGEN, Hilden, Germany) according to the
manufacturer’s instructions. Where indicated, before RNA isolation
confluent cells were detached by treatment with 5 mM EDTA in
PBS, washed twice with serum-free DMEM, resuspended in the
same medium containing 1 M monensin, and plated for 2 h on
tissue culture dishes that had been coated with 10 g/ml polyly-
sine, fibronectin, or vitronectin as previously described (Retta et al.,
1998). A multiplex semiquantitative RT-PCR was used to detect the
relative levels of 3 and 5 or 1 integrin mRNAs. cDNA was
synthesized from 5 g of cytoplasmic RNA with the use of the 1st
Strand cDNA Synthesis kit (Roche Molecular Biochemicals), and
subjected to 28 (3/5) or 32 (1 and 1/3/5) PCR cycles. The
reaction conditions and oligonucleotide PCR primers used were
optimized so that the amplification products fell within the range of
PCR amplification linearity. PCR was performed with each reaction
mixture containing 5 l of cDNA, 1 reaction buffer (Amersham
Pharmacia Biotech AB), 1.5 mM MgCl2, 200 M dNTP, 0.5 M of
each primer, and 2 U of Taq DNA polymerase (Amersham Pharma-
cia Biotech AB) in a total volume of 50 l. The following stages were
used for each PCR cycle: 94°C for 30 s, 55°C for 30 s, and 72°C for
30 s, with a prolonged extension stage of 72°C for 5 min after the
final cycle. The primers were derived from nonhomologous regions
of the mouse 3 and 5 and the human 1 cDNA sequences, and led
to 705-, 570-, and 857-bp PCR products, respectively. PCR products
were electrophoresed on 2% agarose gels and stained with ethidium
bromide. Gels were photographed under UV light and intensities of
the amplified cDNA fragments were quantitated with the use of a
densitometric software (Molecular Analyst; Bio-Rad, Hemel Hemp-
stead, United Kingdom). Molecular size standards (123-bp DNA
ladder) were from Sigma.
For Northern blot hybridization, equal amounts of the purified
total RNA (25 g/lane) were separated by electrophoresis on a 1.2%
agarose gel containing 1.8% formaldehyde and 1 FA Gel buffer [20
mM 3-(N-morpholino)propanesulfonic acid, 5 mM NaAc, 1 mM
EDTA, pH 7.0], transferred to a Nytran SuPerCharge transfer mem-
brane (Schleicher & Schuell, Dassel, Germany) with the use of the
TurboBlotter blotting device accordingly to manufacturer’s instruc-
tions (Schleicher & Schuell), and UV cross-linked to the membrane.
The membrane was prehybridized by incubation in Church’s buffer
(0.5 M Na-phosphate buffer, 10 mg/ml BSA, 7% SDS, 1 mM EDTA,
0.1 mg/ml salmon sperm DNA, pH 7.4) for 8 h at 65°C and hybrid-
ized with 32P-labeled probes overnight at 65°C in Church’s buffer.
After hybridization, the membrane was washed once in 2 SSC 
0.1% SDS, once in 1 SSC  0.1% SDS, once in 0.2 SSC  0.1%
SDS, and once in 0.1 SSC  0.1% SDS for 15 min each at 65°C. The
membrane was then exposed to x-ray film for 24–72 h at 80°C with
an intensifying screen. Probes were synthesized by random priming
with cDNA fragments of mouse 3 and 5 integrin subunits ampli-
fied by PCR and cloned in our laboratory. The same blots were
rehybridized with a probe of the housekeeping gene -actin to
ensure equal loading.
Measurement of mRNA Stability
The measurement of mRNA stability was performed as described by
Xu and Clark (1996). Briefly, cells were divided into three plates and
cultured in 10% FBS/DMEM for 24 h before the addition of 60 M
5,6-dichloro-1--d-ribofuranosyl-benzimidazole (DRB; Sigma), an in-
hibitor of transcription initiation. After addition of DRB, the cells were
collected at 0, 4, 8, 12, and 24 h for RNA analysis. Total RNA isolation
and Northern analysis were performed as described above.
Immunofluorescence Microscopy
Immunofluorescence studies were performed as described previ-
ously (Retta et al., 1996). Briefly, cells were seeded onto fibronectin-
S.F. Retta et al.
Molecular Biology of the Cell3128
coated glass coverslips and allowed to spread for 3 h in complete
culture medium. Cells were then washed with cold PBS, fixed for 10
min with 3.7% paraformaldehyde in PBS, permeabilized with ice-
cold 0.5% Triton X-100, 3.7% paraformaldehyde in PBS for 5 min,
and incubated with 1% BSA in PBS for 30 min. To localize V and 1
integrins, the cells were stained with the rabbit antiserum to V
(1:200 in PBS/1% BSA) or the mAb TS2/16 to 1 (10 g/ml in
PBS/1% BSA). Bound primary antibodies were visualized by ap-
propriate rhodamine-labeled secondary antibodies (1:100). Photo-
graphs were taken on an Olympus BX-60 epifluorescence micro-
scope.
RESULTS
Expression of 1 Integrins Affects Subcellular
Localization of V Integrins
To determine the distribution of V and 1 integrin het-
erodimers on GD25 and GD25-1A cells attached to fi-
bronectin, indirect immunofluorescence experiments with
specific antibodies were performed. GD25 cells, which do
not express 1 integrin heterodimers (Figure 1b), formed
V-containing prominent focal adhesions when allowed to
attach and spread on coverslips coated with fibronectin (Fig-
ure 1a), consistent with the reported ability of V3 to local-
ize to focal adhesions in these cells (Wennerberg et al., 1996;
Retta et al., 1998). In contrast, the amount of V-containing
focal adhesions was consistently reduced on GD25-1A cells
attached to fibronectin (Figure 1c), whereas 1A-containing
focal adhesions were abundant (Figure 1d).
Thus, 1A, by localizing to focal adhesions, displaces the
V-containing heterodimers from these structures. Interest-
ingly, we have previously shown that the expression of two
other human 1 isoforms, namely, 1B, that does not localize
to focal adhesions, and 1D, that is efficiently targeted to
focal adhesions, also causes the delocalization of V het-
erodimers on the cell surface (Belkin et al., 1997; Retta et al.,
1998). Taken together, these data indicate that in GD25 cells
cultured on fibronectin V3 takes over the function of 1
integrins in mediating focal adhesion assembly; however,
when expressed, 1 integrins behave as trans-dominant mol-
ecules with respect to V integrins.
Figure 1. Subcellular localization of V and 1 integrins on GD25 and GD25-1A cells plated on fibronectin. GD25 (a and b) and GD25-1A
(c and d) cells were allowed to attach and spread on coverslips coated with fibronectin (30 g/ml in PBS) for 3 h at 37°C. Cells were then
fixed, permeabilized, and incubated with primary antibodies against V (rabbit anti-V) and 1 (mAb TS2/16) integrin subunits. The V and
1 antibody–antigen complexes were then detected with rhodamine-conjugated anti-rabbit and anti-mouse secondary antibodies, respec-
tively. Representative fields were photographed with the use of an Olympus BM11 microscope fitted with epifluorescence. Notice that 1
integrins displace V integrins from focal adhesions. Bar, 15 m.
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Expression of the 1 Integrin Subunit in GD25 Cells
Induces Drastic Reduction of Surface Level of V3
and an Up-Regulation of V5
Previous results showed that transfection of GD25 cells with
cDNA constructs of human 1 integrin led to surface expres-
sion of the 1 integrin subunit associated with the endoge-
nous 3, 5, and 6 subunits but not with the V subunit
(Retta et al., 1998). In addition, no obvious differences in V
integrin expression were seen by immunoprecipitation from
125I-surface–labeled GD25 and GD25-1A cells with an an-
ti-V antiserum (Retta et al., 1998). To understand the cellu-
lar mechanism(s) controlling the effect of 1 over V inte-
grins, we analyzed more in detail GD25 and GD25-1A cells
for the expression levels of their V integrin heterodimers,
namely, V3 and V5. Untransfected or 1A-transfected
GD25 cells were surface-labeled with Sulfo-NHS-Biotin then
V3 and V5 integrins were immunoprecipitated from
nonionic detergent cell extracts and analyzed by Western
blot. As expected, a polyclonal serum to the V integrin
subunit coimmunoprecipitated V together with its associ-
ated 3 and 5 subunits (Figure 2A). The biotinylated V, 3,
and 5 proteins resulted as distinct bands in Western blots
and, surprisingly, we noticed that, whereas expression of the
V subunit did not change significantly, the relative
amounts of 3 and 5 proteins in 1A-expressing GD25 cells
were clearly different from those of untransfected GD25 cells
(Figure 2A). With the use of antibodies specific for 3 and 5
subunits, we confirmed this evidence: 3 protein levels were
much lower in GD25-1A than in GD25 cells, whereas the
opposite was true for 5 protein levels (Figure 2, B and C).
Thus, although the expression of the human 1A integrin
isoform in GD25 cells did not modify the surface expression
level of the V integrin subunit, it led to a down-regulation
and an up-regulation of the levels of its associated 3 and 5
subunits, respectively. These data suggest that the trans-
dominant effect of 1 integrin isoforms over the subcellular
localization of V integrins in GD25-1 cells is due to a
switching of the relative amounts of the cell-surface expres-
sion levels of V3 and V5 integrins.
Expression of 1 Integrins Differentially Regulates
mRNA Steady-State Levels of 3 and 5 Integrin
Subunits
To address at what level the control of 3 and 5 protein
expression in GD25-1 cells was exercised, we first com-
pared mRNA steady-state levels of these two integrin sub-
units in GD25-1A with those of untransfected GD25 cells,
with the use of both RT-PCR and Northern blot procedures.
A duplex RT-PCR assay with two sets of primers was
developed for the simultaneous detection of the relative
levels of 3 and 5 integrin subunit mRNAs. As shown in
Figure 3A, a great difference in 3 mRNA steady-state levels
was observed between GD25 and GD25-1A cells. Interest-
ingly, the lower mRNA levels of 3 in GD25-1A compared
with those in GD25 cells reflected what we observed at the
level of protein cell-surface expression (compare with Figure
2, A and B). On the contrary, there was little difference in 5
mRNA levels among untransfected and 1-transfected GD25
cells, with a small elevation observed in GD25-1A cells
(Figure 3A). RT-PCR for 1 mRNA was performed as control
(Figure 3B). Thus, the presence of 1 integrins in GD25 cells
differently modulates 3 and 5 mRNA expression.
Northern blot analysis demonstrated that our cDNA
probes to 3 and 5 specifically recognized mRNAs of 6.6
and 3.5 kb, respectively, consistent with what has been
previously described (Yamada et al., 1995). As resulted from
this analysis, the mRNA steady-state level of 3 was much
lower in GD25-1A than in GD25 cells (Figure 3C, 3), thus
reflecting the difference observed by RT-PCR and protein
analysis (see above). In addition, the Northern blot analysis
confirmed that the difference in 5 mRNA steady-state levels
between GD25 and GD25-1A cells (Figure 3C, 5) did not
fully correlate with the difference in 5 cell-surface expres-
sion level (compare with Figure 2, A and C). Thus, in GD25-
1A cells the down-regulation of V3 cell-surface expres-
sion strictly correlates with the down-regulation of 3
mRNA steady-state level, whereas the up-regulation of V5
is mainly due to translational or posttranslational events
leading to an increase of 5 subunit cell-surface recruitment.
Figure 2. Surface expression of v, 3
and 5 integrins in GD25 and GD25-1
cells. Integrin heterodimers were
immunoprecipitated from surface bio-
tinylated untransfected (/) or 1A-
and 1B-transfected GD25 cells with
polyclonal antibodies specific for v
(A), 3 (B), and 5 (C) integrin sub-
units, respectively. After separation by
nonreducing SDS-PAGE and Western
blot, the immunoprecipitated proteins
were detected with the use of peroxi-
dase-conjugated streptavidin and ECL
as described in MATERIALS AND
METHODS. Notice that, although the
expression of either integrin 1 A or B
isoforms does not alter significantly
the expression level of the V integrin
subunit, it induces a net change of the
V3/V5 ratio.
S.F. Retta et al.
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1 Effect over V Integrins Occurs Irrespective of the
Type of 1 Isoform and Is Dependent on the
Presence of the 1 Cytoplasmic Domain Common
Region
We have previously characterized some of the functional
properties of 1B and 1D integrin isoforms, comparing
these properties with those of the common 1A isoform. In
particular, we have shown that the unique cytoplasmic se-
quences of 1B and 1D endow these molecules with dis-
tinctive functional properties with respect to a number of
cellular functions (Balzac et al., 1994; Belkin et al., 1997;
Belkin and Retta, 1998; Calı̀ et al., 1998; Retta et al., 1998).
To analyze more in detail the effects of 1 over 3 and 5
integrins, we tested GD25 cells expressing 1B and 1D
isoforms as well as two 1 deletion mutants lacking almost
the entire cytoplasmic domain (1TR) or the cytoplasmic
domain variable region (1COM) (Retta et al., 1998). Un-
transfected or 1-transfected GD25 cells were surface-la-
beled with Sulfo-NHS-Biotin, and the expression of V3
and V5 integrin heterodimers was examined by immuno-
precipitation and Western blot analysis as described (see
MATERIALS AND METHODS). The V subunit was ex-
pressed at a constant level in all the examined cells (Figures
2A and 4A), whereas a down-regulation of 3 and an up-
regulation of 5 cell-surface levels were seen in either 1B-
(Figures 2 and 4, B and C) or 1d-expressing GD25 cells
(Figure 4, A–C). Moreover, the expression of the 1COM
cytoplasmic domain mutant induced similar effects, al-
though to a lower extent (Figure 4, A–C). However, GD25-
1TR cells, expressing a 1 mutant carrying the deletion of
the cytoplasmic domain (1TR), behaved equivalently to the
1-deficient GD25 cells (Figure 4, A–C).
The spectrum of relative 3 integrin levels in untrans-
fected or 1-transfected GD25 cells compared well with our
subsequent mRNA analysis. In fact, when we analyzed by
RT-PCR and Northern blot the mRNA steady-state level of
the 3 subunit in GD25 cells expressing either 1B, 1D,
1COM or 1TR, we found that in GD25-1B and GD25-1D
cells it was as low as in GD25-1A cells, whereas in GD25-
1COM cells it was also reduced but to a lower extent
(Figure 5, A–C). On the contrary, the 3 mRNA level in
GD25-1TR was higher and similar to that of 1-deficient
GD25 cells (Figure 5, A–C). On the other hand, although a
little increase of 5 mRNA steady-state level was observed
in GD25 cells expressing 1B, 1D, or 1COM (Figure 5, B
and D), it did not fully reflect the high increase observed at
the 5 protein level in the same cells.
These results indicate that the 1-dependent modulation
of 3 and 5 integrin subunit expression was not confined to
GD25-1A cells, but that it was also present in GD25 cells
expressing two other 1 isoforms. In addition, the fact that a
down-regulation of 3 and an up-regulation of 5 were also
observed in GD25-1COM, but not in GD25-1TR cells,
strongly suggests that the control of the expression level of
3 and 5 integrin subunits was dependent on the presence
of the 1 cytoplasmic domain common region.
Cell Adhesion to ECM Proteins Is not Required for
1 Effect on 3 mRNA Steady-State Level
To determine whether cell adhesion to ECM proteins was
required for 1 effect over 3 expression levels, we per-
formed Northern blot analysis of 3 mRNA steady-state
level in cells plated on tissue culture dishes coated with
either polylysine or two ECM proteins, namely, fibronectin
and vitronectin. GD25-1TR and GD25-1COM cells were
cultured to confluence in complete culture medium and then
resuspended in serum-free medium, containing 1 M mo-
nensin, and allowed to attach and spread on polylysine-,
fibronectin-, and vitronectin-coated dishes for 2 h at 37°C
before RNA isolation for Northern blot analysis.
The results, shown in Figure 6, indicate that the 3 mRNA
steady-state level was constitutively low in GD25-1COM
cells compared with that of GD25-1TR cells. Similar results
were obtained by comparing 3 mRNA steady-state levels in
cells kept in suspension in serum-free medium for up to 2 h
with those of long-term adherent cells. Thus, these data
suggest that ligation of ECM proteins is not required for 1
effect over 3 expression.
De Novo Surface Expression of 1-associated 
Subunits Does Not Affect the Level of 3 Integrin
Subunit
Because human 1 expression in GD25 cells leads to the
assembly and cell-surface recruitment of integrin complex
Figure 3. 1 integrins differentially regulate mRNA steady-state
levels of 3 and 5 integrin subunits. Total RNA was isolated from
1  107 cultured GD25 (/) and GD25-1A cells, and 3 and 5
mRNAs were evaluated by RT-PCR and Northern blot analyses as
described in MATERIALS AND METHODS. (A) Duplex RT-PCR
assay for the simultaneous detection of 3 and 5 mRNAs. (B)
RT-PCR for 1 mRNA performed as control. Molecular size stan-
dards (123-bp DNA ladder) are shown on the left. (C) Northern blot:
equal amounts of total RNA (25 g/lane) were probed sequentially
by 32P-labeled mouse integrin 3 and 5 cDNA fragments, and by a
32P-labeled -actin probe as a control for RNA loading. Notice that
the presence of 1 integrins causes a marked down-regulation of 3
and a little up-regulation of 5 mRNA expression levels.
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with endogenous 3, 5, and 6 subunits (Retta et al., 1996),
it was possible that these 1-associated  subunits could
play a direct role in the down-regulation of V3 integrin.
To exclude this possibility we took advantage of GD25-
1TR cells by extending our observations with this cell line.
The expression of the 1TR mutant at the surface of GD25-
1TR cells was comparable with that of the 1A isoform in
GD25-1A cells, as previously determined by flow cytom-
etry analysis (Retta et al., 1998). In addition, by immunopre-
cipitation experiments we did not see any detectable change
in the pattern of  subunits associated with 1TR in GD25
cells compared with GD25-1A cells (Figure 7). Neverthe-
less, the presence of 1TR integrin heterodimers did not lead
to any detectable effect over V3 or V5 integrins (Figures
4, A–C, and 5, A–D). Taken together, these data strongly
suggest that the down-regulation of 3 is not directly due to
de novo surface expression of the 1-associated  subunits
and confirm that for the effect of 1 integrins over V3/
V5 integrin ratio a 1 subunit carrying, at least, the com-
mon region of the cytoplasmic domain is required.
Expression of 1 Integrins Induces a Marked
Decrease in 3 mRNA Stability
Because modulation of mRNA stability is a potential regu-
latory mechanism for integrin expression (Sachs, 1993; Feng
et al., 1999), we next asked whether the changes in mRNA
steady-state levels were due to changes in integrin mRNA
stability. The rate of turnover of 3 and 5 mRNAs was
determined by inhibition of RNA synthesis with 60 M DRB
followed by quantitative blot hybridization analysis of 3
and 5 mRNA as a function of time. In GD25-1A cells
grown on tissue culture dishes a clear decrease of 3 mRNA
stability was detected compared with GD25 cells (Figure
8A). The 3 mRNA decayed with an apparent half-life of 8
h in GD25 cells but 4 h in GD25-1A cells (Figure 8, A and
B). In contrast, the stability of 5 mRNA was much higher
than that of 3, and no significant difference was observed
when GD25 and GD25-1A cells were compared. Therefore,
the effects of 1 expression over 3 and 5 mRNA levels
clearly involve a regulation of 3, but not 5, mRNA stability
DISCUSSION
There is increasing evidence that a coordinated cross talk
between integrin receptors is crucial for an integrated and
functional response of a single cell to the extracellular envi-
ronment (Porter and Hogg, 1997; Blystone et al., 1999; Hynes,
1999). However, the molecular mechanisms of integrin cross
talk remain mostly undetermined.
Previously, we showed that the expression of either 1B or
1D integrin isoforms in 1-null GD25 cells prevented dif-
ferent FN-dependent functions of endogenous V integrins,
including their ability to mediate cell adhesion, to localize to
focal adhesions, and to assembly an FN matrix, thus indi-
cating the existence of a functional cross talk between these
two 1 isoforms and V integrins (Belkin et al., 1997; Retta et
al., 1998). The present study was undertaken to examine this
integrin cross talk and establish the regulatory mecha-
nism(s) whereby 1 integrins exert their trans-acting func-
tions. The main findings are that 1) de novo expression of
the 1 integrin subunit in 1-null GD25 cells induces a
Figure 4. Comparative analysis of surface expression of v integrins
in GD25 cells expressing different integrin 1 forms. (A) v integrin
heterodimers were immunoprecipitated from surface biotinylated
GD25 cells expressing either the 1A or 1D isoforms or two 1 dele-
tion mutants, lacking the entire cytoplasmic domain (1TR) or the
cytoplasmic domain variable region (1COM), with the use of a poly-
clonal antibody against the v subunit. After separation by nonreduc-
ing SDS-PAGE and Western blot, the immunoprecipitated proteins
were detected with the use of peroxidase-conjugated streptavidin and
ECL as described in MATERIALS AND METHODS. (B and C) Scan-
ning densitometry analysis of 3 (B) and 5 (C) integrins as detected by
Western blot. Data are displayed as percentage of the control (GD25)
and are representative of three independent experiments. Notice that
the 1 effect over the V3/V5 ratio occurs irrespective of the type of
the 1 isoform and is dependent on the presence of the 1 cytoplasmic
domain common region.
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drastic down-regulation of V3 and an up-regulation of
V5 integrin cell surface levels; 2) this 1 effect occurs
irrespective of the type of 1 isoform but is dependent on the
presence of the common region of the 1 cytoplasmic do-
main; and 3) the down-regulation of V3 is due to a de-
creased mRNA stability of the 3 subunit, whereas the up-
regulation of V5 is mainly due to translational or
posttranslational events. These findings provide the first
evidence of a cross talk between 1 and V integrins based
on mechanisms of control of mRNA and protein levels.
Figure 5. Comparative analysis of 3 and 5 mRNA steady-state levels in GD25 cells expressing different integrin 1 forms. Total RNA was
isolated from 1  107 cultured cells as described in MATERIALS AND METHODS. (A) Multiplex RT-PCR assay for the simultaneous
detection of 1, 3, and 5 mRNAs in GD25 cells expressing either the 1A, 1B, or 1D isoforms or two 1 deletion mutants lacking the entire
cytoplasmic domain (1TR) or the cytoplasmic domain variable region (1COM). (B) Northern blot: equal amounts of total RNA (25 g/lane)
were probed sequentially by 32P-labeled mouse integrin 3 and 5 cDNA fragments and by a 32P-labeled -actin probe as a control for RNA
loading. The positions of 28s and 18s rRNAs are indicated as markers for RNA sizes. (C and D) Scanning densitometry analysis of 3 and
5 mRNA levels as detected by Northern blot. Northern signals were normalized to -actin and displayed as percentage of the control
(GD25). Data are representative of three independent experiments. Notice that the down-regulation of 3 mRNA steady-state level occurs
irrespective of the type of the 1 isoform and is dependent on the presence of the 1 cytoplasmic domain common region.
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Expression of the 1 Integrin Subunit in GD25 Cells
Induces a Drastic Reduction of Surface Level of
v3 and an Up-Regulation of v5
Despite the apparent high degree of integrin-ligand binding
redundancy (Hynes, 1992), the localization of distinct inte-
grins to focal adhesions is usually very restricted (Fath et al.,
1989). In GD25 cells two integrins are believed to be able to
localize to focal adhesions on fibronectin, namely, V3 and,
upon 1 ectopic expression, 51 (Wennerberg et al., 1996;
Belkin et al., 1997; Retta et al., 1998). However, whereas V
integrins can take over some FN-dependent functions in the
absence of 1 integrins (Wennerberg et al., 1996; Retta et al.,
1998), immunofluorescence analyses of 1A-transfected and
untransfected GD25 cells plated on fibronectin show that 1
integrins clearly dominate upon V integrins in localizing to
focal adhesions. This phenomenon is mainly due to a cross
talk between 1 and V integrins that occurs at the level of
expression on the cell surface. In fact, although the presence
of 1 integrins in GD25 cells does not affect the total amount
of V integrins, it causes a clear rearrangement of the relative
cell surface levels of 3 and 5 subunits, leading to a marked
down-regulation of V3 and a correspondent up-regulation
of V5.
A great deal of experimental work has shown that integrin
expression is highly dynamic during development (re-
viewed in Darribere et al., 2000; Tarone et al., 2000). In
particular, it has been suggested that the presence and func-
tions of the V integrins are developmentally controlled by
differential temporal and spatial regulation of its  subunits
(Yamada et al., 1995), whereas there are reports showing that
a balanced ratio of integrin receptors is crucial for the main-
tenance of the differentiation state of a particular cell (Carroll
et al., 1995; Sastry et al., 1996). However, genetic ablation
experiments have shown that the absence of some widely
expressed integrins that were believed to be key regulators
of development and differentiation has resulted into mild or
late phenotypes. In particular, it has come out that processes
such as myogenesis, vasculogenesis, and angiogenesis,
which through antibody or peptide perturbation experi-
ments were shown to be dependent on specific 1 or V
integrins, can actually proceed without these integrins
(Bader et al., 1998; Hirsch et al., 1998), suggesting that there
might be some overlapping or compensatory functions be-
tween different integrins. A very striking example of this
point comes from a thorough study of compound mutations
showing that gene knockouts of V and 5 integrin subunits
have synergistic effects when combined pairwise and result
in a phenotype similar to that of FN-null mutation, suggest-
ing that 51 and V integrins normally overlap or can
compensate each other in mesodermal development (Yang
et al., 1999). Other examples derive from in vitro experiments
showing that in cultured cells V integrins are able to com-
pensate for the loss of the 51 fibronectin receptors (Wen-
nerberg et al., 1996; Yang and Hynes, 1996; Retta et al., 1998).
On the other hand, V3 has previously been shown to
negatively regulate 51-mediated cell migration (Bilato et
al., 1997; Simon et al., 1997; Blystone et al., 1999) and phago-
cytosis (Blystone et al., 1994, 1999). Notably, the above-cited
reports are all examples of functional cross talk between V
and 1 integrins, apparently without quantitative up-regu-
lation of integrin levels. Our present report now demon-
strates that, besides the existence of a functional compensa-
Figure 7. Pattern of  subunits associated with the 1TR cytoplas-
mic domain deletion mutant. (A) 1 Integrins immunoprecipitated
from surface biotinylated 1A- and 1TR-transfected GD25 cells
with the mAb TS2/16. (B) Integrin heterodimers immunoprecipi-
tated from surface biotinylated GD25-1TR cells with the mAb
GoH3 against 6 and polyclonal antibodies against 3 and 5 inte-
grin subunits. After separation by nonreducing SDS-PAGE and
Western blot, the immunoprecipitated proteins were detected with
the use of peroxidase-conjugated streptavidin and ECL as described
in MATERIALS AND METHODS. Notice that the 1TR mutant
correctly associates with three major  subunits at the surface of
GD25-1TR cells.
Figure 6. Cell adhesion to ECM proteins is not required for 1
effect on 3 mRNA steady-state level. GD25-1TR and GD25-
1COM cells were cultured to confluence in complete culture me-
dium. Cells were then resuspended in serum-free medium contain-
ing 1 M monensin and allowed to attach and spread on polylysine-
(PL), FN-, or vitronectin (VN)-coated tissue culture dishes for 2 h at
37°C before lysis. Total RNA was isolated as described in MATE-
RIALS AND METHODS, and equal amounts (25 g/lane) were
analyzed for 3 mRNA steady-state level by Northern blot hybrid-
ization with the use of 32P-labeled mouse integrin 3 cDNA frag-
ments as probe. Equal loading was confirmed by hybridization of
the same blot with a 32P-labeled probe for -actin. The positions of
28s and 18s rRNAs are indicated as markers for RNA sizes. Notice
that the 3 mRNA steady-state level is constitutively low in GD25-
1COM compared with that of GD25-1TR cells.
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tion of V integrins for the lack of certain 1 integrin
functions, a cross talk mechanism occurs that regulates the
ratio of V3 and V5 on the cell surface upon 1 integrin
expression. Taken together, these observations suggest that
the cross talk between 1 and V integrins must be bidirec-
tional, articulate, and based on integrated and tightly regu-
lated mechanisms. Several examples support the existence of
such a composite cross talk between integrins. One example
comes from our recent report showing that ectopic expres-
sion of 7B integrin subunit in Chinese hamster ovary cells
leads to down-regulation of both cell surface expression and
ligand binding affinity of the integrin 51 (Tomatis et al.,
1999). Another straightforward example derives from anal-
ysis of the expression of 1 splice variants during mouse
muscle development: genetic analysis by homologous re-
combination has demonstrated that mice lacking 1D, the
only 1 isoform in adult muscles, develop normally without
gross apparent defects; in this case, however, the 1A iso-
form is not down-regulated as in wild-type muscles and can
apparently compensate both in function and in level for the
absence of 1D (Baudoin et al., 1998). A similar phenomenon
might likely occur during 1-null myoblast differentiation
where an up-regulation of V3, both in level and function,
could give a reason for the unexpected mild phenotype
(Hirsch et al., 1998). Interestingly, V3 has been recently
shown to be up-regulated in 1-null cardiac cells compared
with wild-type cells (Guan et al., 2001). On the other hand, a
switch from V5 to V3 integrins has been observed to
occur in important biological processes, including wound
healing (Clark et al., 1996a,b) and tumor progression in situ
(Marshall et al., 1991; Li et al., 1998). Thus, taken together
with the above-mentioned observations, our results support
the hypothesis that the enigma of the recurrent discrepancy
between blocking experiments and genetic analyses (Hynes,
1996; Brakebusch et al., 1997; Bader et al., 1998; Hirsch et al.,
1998; McHugh et al., 2000) could be explained by taking into
account that a compensatory up-regulation both in level and
function between integrins can occur.
Expression of 1 Integrins Differentially Regulates
mRNA Steady-State Levels of 3 and 5 Integrin
Subunits
The expression of integrins can be modulated by a variety of
agents, including proinflammatory cytokines, growth fac-
tors, hormones, extracellular matrix components, and phar-
macological agents (Delcommenne and Streuli, 1995; Kim
and Yamada, 1997). In particular, the integrin V3 has been
shown to be up-regulated by transforming growth factor-1,
platelet-derived growth factor-BB (Janat et al., 1992), basic
fibroblast growth factor (Sepp et al., 1994), vitamin D (Med-
hora et al., 1993), fibronectin (Feng et al., 1999), and phorbol
esters (Swerlick et al., 1992), and down-regulated by tumor
necrosis factor-, interferon- (Defilippi et al., 1991), and
collagen (Feng et al., 1999). Mechanisms regulating integrin
expression include regulation of protein levels by transcrip-
tional or posttranscriptional events, alternative splicing of
mRNA, and mobilization of preexisting intracellular stores
(Xu and Clark, 1996; Kim and Yamada, 1997). However,
little is known regarding integrin cross talk mechanisms that
modulate integrin ratios in individual cells. Here, we show
that the expression of 1 integrins in GD25 cells regulates the
cell surface levels of V3 and V5 by two distinct mecha-
nisms. In particular, the decreased expression of integrin
V3 in GD25-1A cells clearly involves an increased decay
rate of 3 subunit mRNA. On the contrary, because the
up-regulation of the 5 protein level we observed was not
reflected at the mRNA level, the enhanced cell surface ex-
pression of V5 is probably mainly due to the mobilization
to the cell surface of intracellular stores of the 5 subunit.
This is consistent with previous reports showing the pres-
ence of intracellular pools of  subunits and indicating the
Figure 8. The presence of the 1 cytoplasmic domain doubles the
decay rate of the 3 mRNA in GD25 cells. GD25-1A and GD25-
1TR cells grown to confluence were divided into three 10-cm Petri
dishes and cultured in DMEM containing 10% FBS for 24 h before
the addition of 60 M DRB, an inhibitor of transcription initiation.
After addition of DRB, the cells were collected at 0, 4, and 8 h for
RNA analysis. Total RNA isolation and Northern analysis were
performed as described in MATERIALS AND METHODS. (A)
Northern blot: equal amounts of total RNA (25 g/lane) were
probed sequentially by 32P-labeled mouse integrin 3 and -actin
cDNA fragments. (B) Scanning densitometry analysis of 3 mRNA
levels as detected by Northern blot. 3 Northern signals were nor-
malized to -actin and displayed as percentage of the baseline (time
0). Data presented are the mean values  SE of three independent
experiments. Notice the lower stability of 3 integrin subunit mRNA
in GD25-1A than in GD25-1TR cells.
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availability of the  subunit as a rate-limiting step in integrin
complex assembly and cell-surface expression (Swerlick et
al., 1992).
The regulation of mRNA stability is a very important
mechanism of posttranscriptional regulation of gene expres-
sion, and evidence exists for both a wide range of half-lives
for different mRNAs in the same cells and different half-lives
for the same mRNA in the same cell under different circum-
stances (Sachs, 1993). Interestingly, it has been previously
suggested that coordinate signals from ECM molecules and
growth factors can modulate the mRNA decay rate of spe-
cific integrins (Xu and Clark, 1996). In addition, a recent
report shows that the 3 mRNA stability can be increased by
cell interaction with fibrin but not with collagen (Feng et al.,
1999). Because most extracellular matrix proteins signal
through integrins, which have also been shown to physically
associate and act synergistically with growth factor recep-
tors (Giancotti and Ruoslahti, 1999), it is possible to hypoth-
esize a scenario where the expression of a specific integrin
can influence the expression of another integrin by affecting
its mRNA stability, either directly or with the cooperation of
an associated growth factor receptor. This could be a way for
a rapid change of integrin ratios in response to a variation of
the extracellular environment, as it occurs during tissue
formation or repair. Interestingly, V3 expression has been
shown to increase focally and transiently during cutaneous
wound repair (Feng et al., 1999). On the other hand, the
existence of this regulatory integrin cross talk could explain
the compensatory up-regulation of V3 in the absence of 1
integrins, highlighting the usefulness of stabilizing specific
integrin mRNA only when it is needed.
1 Effect over 3 Expression Is Dependent on the
Presence of the 1 Cytoplasmic Domain Common
Region
Our results clearly demonstrate that the control of 3/5
ratio is 1-dependent, and neither confined to a particular
cell population nor restricted to a specific 1 isoform. In-
stead, it requires the presence of the common region of the
1 cytoplasmic domain. In addition, the fact that the 1COM
mutant does not contribute to cell adhesion (Retta et al.,
1998), together with the observation that the 3 mRNA
steady-state level is constitutively low in GD25-1COM cells
compared with GD25-1TR cells, indicates that the binding
of extracellular ligands is not required for 1 to regulate 3
expression. On the other hand, it is noteworthy that, al-
though in long-term adherent cells the 1COM mutant was
less effective than 1A in inducing an effect over the 3
mRNA steady-state level, no significant difference was ob-
served when we compared 3 mRNA levels in GD25-
1COM and GD25-1A cells either plated on polylysine or
kept in suspension for 2 h (unpublished). These results could
be explained by taking into account that, in contrast with the
expression of 1A, the expression of 1COM in GD25 cells
does not entirely prevent the localization of V integrins to
FN-dependent focal adhesions (Retta et al., 1998). Thus, a
likely possibility is that the common region of the 1 cyto-
plasmic domain is able to constitutively induce a down-
regulation of 3 mRNA steady-state level; however, the
V3 integrin, due to its ability to localize to focal adhesions
in GD25-1COM cells, counteracts this 1 constitutive action
leading to a mild effect on 3 expression level. Interestingly,
in accordance with a recent report (Feng et al., 1999), the
higher 3 mRNA level in cells cultured on fibronectin or
vitronectin than on polylysine (Figure 6) suggests that ECM
proteins that are ligands for V3 can sustain 3 mRNA
steady-state level.
In conclusion, our results indicate a novel mechanism of
integrin cross talk where one integrin can regulate the ex-
pression of another by modulating the decay rate of its
mRNA. The biological implications of this integrin cross talk
are potentially of high functional significance as a fine-tuned
mechanism for selective and transient integrin expression in
different extracellular contexts. Our attempt now will be to
uncover 1-dependent events regulating the 3 mRNA
steady-state levels.
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We thank Reinhard Fässler and Arnoud Sonnenberg for generously
providing GD25 cells and mAb GoH3, respectively. The students
Tiziana Spatola and Federica Logrand are gratefully acknowledged
for helping in some experiments. We also thank Fiorella Balzac and
Emilio Hirsch for helpful discussions. This work was supported by
grants from the Italian Association for Cancer Research to G.T.,
from the University of Torino (ex 60%) to SFR and GT and from the
University of Palermo (ex 60%) to GDL.
REFERENCES
Albelda, S.M., Mette, S.A., Elder, D.E., Stewart, R., Damjanovich, L.,
Herlyn, M., and Buck, C.A. (1990). Integrin distribution in malig-
nant melanoma: association of the 3 subunit with tumor progres-
sion. Cancer Res. 50, 6757–6764.
Bader, B.L., Rayburn, H., Crowley, D., and Hynes, R.O. (1998).
Extensive vasculogenesis, angiogenesis, and organogenesis precede
lethality in mice lacking all v integrins. Cell 95, 507–519.
Balzac, F., Retta, S.F., Albini, A., Melchiorri, A., Koteliansky, VE.,
Geuna, M., Silengo, L., and Tarone, G. (1994). Expression of 1B
integrin isoform in CHO cells results in a dominant negative effect
on cell adhesion and motility. J. Cell Biol. 127, 557–565.
Baudoin, C., Goumans, M.J., Mummery, C., and Sonnenberg, A.
(1998). Knockout and knockin of the 1 exon D define distinct roles
for integrin splice variants in heart function and embryonic devel-
opment. Genes Dev. 12, 1202–1216.
Belkin, A.M., and Retta, S.F. (1998). 1D integrin inhibits cell cycle
progression in normal myoblasts and fibroblasts. J. Biol. Chem. 273,
15234–15240.
Belkin, A.M., Retta, S.F., Pletjushkina, O.Y., Balzac, F., Silengo, L.,
Fassler, R., Koteliansky, VE., Burridge, K., and Tarone, G. (1997).
Muscle 1D integrin reinforces the cytoskeleton-matrix link: mod-
ulation of integrin adhesive function by alternative splicing. J. Cell
Biol. 139, 1583–1595.
Bilato C, Curto KA, Monticone RE, Pauly RR, White AJ, Crow MT.
(1997). The inhibition of vascular smooth muscle cell migration by
peptide and antibody antagonists of the v3 integrin complex is
reversed by activated calcium/calmodulin-dependent protein ki-
nase II. J. Clin. Invest. 100, 693–704.
Blystone, S.D., Graham, IL., Lindberg, F.P., and Brown, E.J. (1994).
Integrin v3 differentially regulates adhesive and phagocytic func-
tions of the fibronectin receptor 51. J. Cell Biol. 127, 1129–1137.
Blystone, S.D., Slater, S.E., Williams, M.P., Crow, M.T., and Brown,
E.J. (1999). Molecular mechanism of integrin crosstalk: v3 sup-
S.F. Retta et al.
Molecular Biology of the Cell3136
pression of calcium/calmodulin-dependent protein kinase II regu-
lates 51 function. J. Cell Biol. 145, 889–897.
Brakebusch, C., Hirsch, E., Potocnik, A., and Fassler, R. (1997).
Genetic analysis of 1 integrin function: confirmed, new and revised
roles for a crucial family of cell adhesion molecules. J. Cell Sci. 110,
2895–2904.
Brooks, P.C., Clark, R.A., and Cheresh, D.A. (1994). Requirement of
vascular integrin v3 for angiogenesis. Science 264, 569–571.
Calı̀ G, Retta SF, Negri R, Damiano I, Gentile R, Tarone G, Nitsch L,
Garbi C. (1998). 1B integrin interferes with matrix assembly but not
with confluent monolayer polarity, and alters some morphogenetic
properties of FRT epithelial cells. Eur. J. Cell Biol. 75, 107–117.
Carroll, J.M., Romero, M.R., and Watt, F.M. (1995). Suprabasal in-
tegrin expression in the epidermis of transgenic mice results in
developmental defects and a phenotype resembling psoriasis. Cell
83, 957–968.
Clark, R.A., Ashcroft, G.S., Spencer, M.J., Larjava, H., and Ferguson,
M.W. (1996b). Re-epithelialization of normal human excisional
wounds is associated with a switch from v5 to v6 integrins.
Br. J. Dermatol. 135, 46–51.
Clark, R.A., Tonnesen, M.G., Gailit, J., and Cheresh, D.A. (1996a).
Transient functional expression of v3 on vascular cells during
wound repair. Am. J. Pathol. 148, 1407–1421.
Corbett, S.A., and Schwarzbauer, J.E. (1999). 3 integrin activation
improves v3-mediated retraction of fibrin matrices. J. Surg. Res.
83, 27–31.
Critchley, D.R. (2000). Focal adhesions—the cytoskeletal connection.
Curr. Opin. Cell Biol. 12, 133–139.
Darribere, T., Skalski, M., Cousin, H.L., Gaultier, A., Montmory, C.,
and Alfandari, D. (2000). Integrins: regulators of embryogenesis.
Biol. Cell 92, 5–25.
Defilippi, P., Retta, S.F., Olivo, C., Palmieri, M., Venturino, M.,
Silengo, L., and Tarone, G. (1995). p125FAK tyrosine phosphoryla-
tion and focal adhesion assembly: studies with phosphotyrosine
phosphatase inhibitors. Exp. Cell Res. 221, 141–152.
Defilippi, P., Truffa, G., Stefanuto, G., Altruda, F., Silengo, L., and
Tarone, G. (1991). Tumor necrosis factor  and interferon gamma
modulate the expression of the vitronectin receptor (integrin 3) in
human endothelial cells. J. Biol. Chem. 266, 7638–7645.
Delcommenne, M., and Streuli, C.H. (1995). Control of integrin
expression by extracellular matrix. J. Biol. Chem. 270, 26794–26801.
Fassler, R., Georges-Labouesse, E., and Hirsch, E. (1996). Genetic
analyses of integrin function in mice. Curr. Opin. Cell Biol. 8,
641–646.
Fath, K.R., Edgell, C.J., and Burridge, K. (1989). The distribution of
distinct integrins in focal contacts is determined by the substratum
composition. J. Cell Sci. 92, 67–75.
Feng, X., Clark, R.A., Galanakis, D., and Tonnesen, M.G. (1999).
Fibrin and collagen differentially regulate human dermal microvas-
cular endothelial cell integrins: stabilization of v/3 mRNA by
fibrin1. J. Invest. Dermatol. 113, 913–919.
Fornaro, M., and Languino, L.R. (1997). Alternatively spliced vari-
ants: a new view of the integrin cytoplasmic domain. Matrix Biol.
16, 185–193.
Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincaid, C.M., Varner,
J.A., and Cheresh, D.A. (1995). Definition of two angiogenic path-
ways by distinct v integrins. Science 270, 1500–1502.
Giancotti, F.G. (1997). Integrin signaling: specificity and control of
cell survival and cell cycle progression. Curr. Opin. Cell Biol. 9,
691–700.
Giancotti, F.G. (2000). Complexity and specificity of integrin signal-
ing. Nat. Cell Biol. 2, E13–E14.
Giancotti, F.G., and Ruoslahti, E. (1999). Integrin signaling. Science
285, 1028–1032.
Guan, K., Czyz, J., Furst, D.O., and Wobus, A.M. (2001). Expression
and cellular distribution of (v) integrins in (1) integrin-deficient
embryonic stem cell-derived cardiac cells. J. Mol. Cell Cardiol. 33,
521–532.
Hirsch, E., Lohikangas, L., Gullberg, D., Johansson, S., and Fassler,
R. (1998). Mouse myoblasts can fuse and form a normal sarcomere
in the absence of 1 integrin expression. J. Cell Sci. 111, 2397–2409.
Hodivala-Dilke, K.M., McHugh, K.P., Tsakiris, D.A., Rayburn, H.,
Crowley, D., Ullman-Cullere, M., Ross, F.P., Coller, B.S., Teitel-
baum, S., and Hynes, R.O. (1999). 3-integrin-deficient mice are a
model for Glanzmann thrombasthenia showing placental defects
and reduced survival. J. Clin. Invest. 103, 229–238.
Hynes, R.O. (1992). Integrins: versatility, modulation, and signaling
in cell adhesion. Cell 69, 11–25.
Hynes, R.O. (1996). Targeted mutations in cell adhesion genes: what
have we learned from them? Dev. Biol. 180, 402–412.
Hynes, R.O. (1999). Cell adhesion: old and new questions. Trends
Cell Biol. 9, 33–37.
Janat, M.F., Argraves, W.S., and Liau, G. (1992). Regulation of
vascular smooth muscle cell integrin expression by transforming
growth factor 1 and by platelet-derived growth factor-BB. J. Cell
Physiol. 151, 588–595.
Kim, L.T., and Yamada, K.M. (1997). The regulation of expression of
integrin receptors. Proc. Soc. Exp. Biol. Med. 214, 123–131.
Klemke, R.L., Yebra, M., Bayna, E.M., and Cheresh, D.A. (1994).
Receptor tyrosine kinase signaling required for integrin v5-di-
rected cell motility but not adhesion on vitronectin. J. Cell Biol. 127,
859–866.
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